The recent study conducted by Zeng [69] demonstrated that resveratrol tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) combination treatment was able to sensitize renal cell carcinoma (RCC) cells to TRAIL-induced death in vitro. The gene discussed is TNFSF10; the disease is renal cell carcinoma.